Jan. 5 at 3:59 AM
ER run up play this week.
$SLP Simulations Plus, Inc. (NASDAQ: SLP) is a U.S.-based software and services company that provides modeling and simulation tools for pharmaceutical research and development.
Headquartered in Lancaster, California, its platforms are used to predict drug behavior, optimize dosing, and support regulatory submissions.
The company serves pharmaceutical companies, biotech firms, and regulatory agencies worldwide.
Buy:
$17.62
Sell:
$19.00
Stoploss:
$16.75
Chart: